Results 201 to 210 of about 59,312 (243)

Recent Advances in Mesothelioma Treatment: Immunotherapy, Advanced Cell Therapy, and Other Innovative Therapeutic Modalities. [PDF]

Cancers (Basel)
Suraya R, Nagano T, Tachihara M.
europepmc   +1 more source

Rare Metastatic Mesothelioma Occupying Intra-Atrial Cavity, Released by an Emergency Surgery: A Case Report and Literature Review. [PDF]

Surg Case Rep
Takano T, Sato S, Ito I, Yamamoto M, Tsukioka K, Matsumura Y, Kono T.   +6 more
europepmc   +1 more source

Trends in Mesothelioma Mortality in the United States Between 1999 and 2020. [PDF]

JTO Clin Res Rep
Didier AJ, Li M, Gheeya J, Alahmadi A, Kaufman J, Memmott R, He K, Shields P, Carbone DP, Presley C, Owen D, Roof L.   +11 more
europepmc   +1 more source

Enhanced Detection of Recurrent Diffuse Malignant Peritoneal Mesothelioma Using ⁶⁸ Ga-FAPI PET/CT Compared to ¹⁸ F-FDG PET/CT: A Case Report. [PDF]

World J Nucl Med
Abdulrahman M, Al-Rasheed U, Dabous A, Al-Ibraheem A.   +3 more
europepmc   +1 more source

Mesothelioma cell heterogeneity identified by single cell RNA sequencing. [PDF]

Sci Rep
Wu L, Wang Z, Zia A, Kelley SO, de Perrot M.   +4 more
europepmc   +1 more source

FABP5 is a key player in metabolic modulation and NF-κB dependent inflammation driving pleural mesothelioma. [PDF]

Commun Biol
Vecchio E, Gallo R, Mimmi S, Gentile D, Giordano C, Straface E, Marino R, Caiazza C, Pastore A, Ruocco MR, Arcucci A, Schiavone M, Palmieri C, Iaccino E, Stornaiuolo M, Quinto I, Mallardo M, Martini F, Tognon M, Fiume G.   +19 more
europepmc   +1 more source

Causal effect of gut microbiota on the risk of cancer and potential mediation by inflammatory proteins. [PDF]

World J Surg Oncol
Wang Y, Liu W, Liu L, He Y, Luo H, Fang C.   +5 more
europepmc   +1 more source

Comprehensive genomic and transcriptomic analysis enables molecularly guided therapy options in peritoneal and pleural mesothelioma. [PDF]

ESMO Open
Möhrmann L, Werner M, Oleś M, Knol L, Arnold JS, Mundt T, Paramasivam N, Richter D, Fröhlich M, Hutter B, Hüllein J, Jahn A, Scheffold C, Möhrmann EE, Hanf D, Kreutzfeldt S, Heilig CE, Teleanu MV, Lipka DB, Beck K, Baude-Müller A, Jelas I, Rieke DT, Klotz LV, Shah R, Herold T, Boerries M, Illert AL, Allgäuer M, Stenzinger A, Kerle IA, Horak P, Heining C, Schröck E, Hübschmann D, Fröhling S, Glimm H.   +36 more
europepmc   +1 more source

Asbestos and benign pleural diseases: a narrative review. [PDF]

Breathe (Sheff)
Ferreiro L, Toubes ME, Rodríguez-Núñez N, Valdés L.   +3 more
europepmc   +1 more source